We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.06%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$66.5B
AUM Growth
+$8.68B
(+15%)
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
43.86%
Holding
2,667
New
353
Increased
1,277
Reduced
719
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$322M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$296M |
| 3 |
Avantis US Equity ETF
AVUS
|
+$283M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
+$280M |
| 5 |
Vanguard Total Bond Market
BND
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$76.1M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$59.3M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$20.7M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$19.6M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.02% |
| 2 | Financials | 2.97% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.4% |
| 5 | Consumer Staples | 1.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNF
2276
CNFinance Holdings
CNF
$40.3M
| $33K | ﹤0.01% |
+1,932
| New | +$39.6K |
|
2277
Cytosorbents Corp
CTSO
$22.6M
| $33K | ﹤0.01% |
21,295
| – | – |
|
|
GOL
2278
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $32.8K | ﹤0.01% |
+12,281
| New | +$40K |
|
|
CTEV
2279
Claritev Corp
CTEV
$368M
| $32.8K | ﹤0.01% |
+712
| New | +$56.9K |
|
2280
Globalstar
GSAT
$10.2B
| $32.1K | ﹤0.01% |
1,610
+149
| +10% | +$3.92K |
|
2281
Perspective Therapeutics
CATX
$332M
| $32K | ﹤0.01% |
12,950
| – | – |
|
2282
CALL
iShares Russell 2000 ETF
IWM
$80.9B
| $31.9K | ﹤0.01% |
1,500
+900
| +150% | +$160K |
|
2283
VolitionRx Ltd
VNRX
$12M
| $31.9K | ﹤0.01% |
+657
| New | +$25.5K |
|
|
SFIX
2284
Stitch Fix
SFIX
$478M
| $31.7K | ﹤0.01% |
+10,189
| New | +$38.1K |
|
2285
Aveanna Healthcare
AVAH
$2.06B
| $31.2K | ﹤0.01% |
+40,000
| New | +$41.9K |
|
2286
Lineage Cell Therapeutics
LCTX
$257M
| $30.8K | ﹤0.01% |
26,291
-77
| -0.3% | -$97 |
|
2287
AtaiBeckley Inc
ATAI
$2.66B
| $30.3K | ﹤0.01% |
11,377
+265
| +2% | +$805 |
|
|
DOCU
2288
CALL
DocuSign
DOCU
$9.63B
| $29.9K | ﹤0.01% |
2,500
| – | – |
|
2289
CALL
Intel
INTC
$466B
| $29.8K | ﹤0.01% |
11,500
| – | – |
|
2290
BARK
BARK
$74.8M
| $29.8K | ﹤0.01% |
+1,000
| New | +$33.3K |
|
|
RIDE
2291
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $28.9K | ﹤0.01% |
+1,690
| New | +$39.2K |
|
2292
SAB Biotherapeutics
SABS
$268M
| $28.6K | ﹤0.01% |
4,852
+100
| +2% | +$914 |
|
2293
Grupo Aval
AVAL
$5.67B
| $28.4K | ﹤0.01% |
+11,213
| New | +$25.9K |
|
2294
PUT
Snowflake
SNOW
$92.9B
| $27.8K | ﹤0.01% |
+3,500
| New | +$534K |
|
|
URG
2295
Ur-Energy
URG
$485M
| $27.6K | ﹤0.01% |
24,035
-100
| -0.4% | -$122 |
|
|
BRFS
2296
DELISTED
BRF SA
BRFS
| $26.5K | ﹤0.01% |
+16,767
| New | +$34.8K |
|
2297
CleanSpark
CLSK
$3.73B
| $26.4K | ﹤0.01% |
12,939
+246
| +2% | +$637 |
|
2298
Gevo
GEVO
$396M
| $26.3K | ﹤0.01% |
13,837
+1,890
| +16% | +$3.99K |
|
2299
CALL
Apple
AAPL
$4.89T
| $25.4K | ﹤0.01% |
3,600
+2,700
| +300% | +$386K |
|
2300
Aqua Metals
AQMS
$9.63M
| $25.4K | ﹤0.01% |
101
| – | – |
|
Similar funds
Creative Planning's Q4 2022 Portfolio in Review
As of Q4 2022, Creative Planning held 2,667 positions worth $66.5B, up 15% from $57.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Creative Planning deployed $4.4B of net new capital in Q4 2022, opening 353 new positions and adding to 1,277 existing holdings. Its largest new stake was Avantis US Equity ETF: 4,140,930 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 ETF, an estimated $76.1M trimmed.
- Creative Planning's largest Q4 2022 buy was Avantis US Equity ETF: 4,140,930 shares worth $282M.
- Creative Planning added most to iShares Core MSCI International Developed Markets ETF in Q4 2022, an estimated $322M increase.
- Creative Planning's biggest Q4 2022 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $76.1M.
- Creative Planning fully exited Veradigm Inc. Common Stock in Q4 2022, selling an estimated $19.6M.
- Creative Planning's ten largest holdings make up 44% of its $66.5B portfolio in Q4 2022.
- Creative Planning opened 353 new positions and closed 180 in Q4 2022.
- Creative Planning's portfolio value rose 15% quarter-over-quarter to $66.5B.
Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.